CN Stock MarketDetailed Quotes

002393 Tianjin Lisheng Pharmaceutical

Watchlist
  • 17.20
  • +0.52+3.12%
Not Open Apr 1 15:00 CST
4.43BMarket Cap24.02P/E (TTM)

Tianjin Lisheng Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Product Currency:CNY
2024/FY
Stock NameRevenueRatio
Tablet828.58M62.01%
Injection193.53M14.48%
Pills124.38M9.31%
Capsule104.98M7.86%
Other60.11M4.50%
Granule24.57M1.84%
View all
Industry Currency:CNY
2024/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing1.34B100.00%
Region Currency:CNY
2024/FY
Stock NameRevenueRatio
North China497.76M37.25%
East China region307.6M23.02%
Central and southern region280.25M20.97%
Southwest area113.43M8.49%
Northwest region73.55M5.50%
Northeast area61.17M4.58%
Exit2.38M0.18%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
No. Symbol % Chg
OKAY
833230
+29.96%
CHANGFU CO.,LTD
871396
+24.59%
Gansu Longshenrongfa Pharmaceutical Industry
300534
+20.05%
4
Tibet Duo Rui Pharmaceutical
301075
+20.02%
5
Chengda Pharmaceuticals
301201
+20.01%
Log In for the Full List
Unlock Now